© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Grace Halsey
Articles
Novavax Releases Promising Data from Descriptive Trial for COVID/Flu Combination and Stand-Alone Flu Vaccines
June 11, 2025
Both investigational vaccines induced strong immunity across all antigens and researchers reported no new safety signals, supporting phase 3 development.
Lebrikizumab Demonstrates Efficacy, Safety in Patients With Skin of Color With AD
June 11, 2025
RAD 2025. Lebrikizumab improved skin clearance, itch, and pigmentation in patients with skin of color and atopic dermatitis, with strong safety data through 24 weeks, according to late-breaking data.
The US Adult Vaccination Gap: New Analysis Quantifies the Divide, Recommends Solutions
June 11, 2025
Vaccination rates among US adults are roughly half that of pediatric populations, exposing older adults to risk for disease and complications, according to a new analysis.
Flexible Dosing in in Atopic Dermatitis Treatment: Notes on Real-World Use with Raj Chovatiya, MD, PhD, MSCI
June 11, 2025
RAD 2025: Chovatiya spoke at RAD about the need to better understand how treatments for AD are being used in the real world, after symptoms subside and skin signs clear.
Understanding Chronic Hand Eczema: More Than Just Atopic Dermatitis
June 10, 2025
RAD 2025: Jiade Yu, MD, discussed chronic hand eczema as a distinct condition from AD, highlighting its clinical burden and emerging treatments, such as delgocitinib.
Arcutis Begins Study of Roflumilast Cream 0.05% in Infants with Atopic Dermatitis
June 10, 2025
Arcutis Biotherapeutics announced today the enrollment of the first patient in the phase 2 INTEGUMENT-INFANT trial.
George Medicines Announces FDA Approval of Polypill for Treatment of Hypertension in Adults
June 10, 2025
The novel triple fixed-dose combination of telmisartan, amlodipine and indapamide, is the first of its kind approved for initial treatment of hypertension.
2025 ACOG Annual Clinical & Scientific Meeting: What You May Have Missed
June 10, 2025
From primary care management of heavy menstrual bleeding to postpartum depression screening, find out what you may have missed at ACOG 2025.
Clesrovimab Wins FDA Approval for Prevention of RSV LRTD in Infants During First RSV Season
June 10, 2025
The preventive monoclonal antibody is designed to protect infants against RSV infection through 5 months and is administered at the same dose, regardless of weight.
Q&A: Cumulative Life Course Impairment of Atopic Dermatitis with Mona Shahriari, MD
June 10, 2025
RAD 2025: As expert dermatologist Shahriari explains it, eczema may be just another rash on your schedule but for a patient, it could be the reason they don't leave the house.